Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul;36(6):1719-1721.
doi: 10.1007/s40620-023-01699-5. Epub 2023 Jul 6.

Bivalent vaccination against COVID-19 can trigger a humoral response in immunocompromised patients who receive monoclonal antibody prophylaxis

Pierre Housset  1 , Christine Bouhelier  2 , Agathe Pardon  2 , Latifa Hanafi  2 , Nathalie Vittoz  2 , Dogan-Firat Bozman  2 , Wassila Amar  2 , Valérie Caudwell  2 , Thibaut Charlemagne  2
Affiliations

Bivalent vaccination against COVID-19 can trigger a humoral response in immunocompromised patients who receive monoclonal antibody prophylaxis

Pierre Housset et al. J Nephrol. 2023 Jul.
No abstract available

Keywords: COVID-19; Humoral response; Immunosuppression; Monoclonal antibody; SARS-CoV-2; Transplantation; mRNA vaccine.

PubMed Disclaimer

References

    1. Arora P, Kempf A, Nehlmeier I et al (2023) Omicron sublineage BQ.1.1 resistance to monoclonal antibodies. Lancet Infect Dis 23(1):22–23. https://doi.org/10.1016/S1473-3099(22)00733-2 . (Published correction appears in Lancet Infect Dis. 2022 Nov 29) - DOI - PubMed
    1. Schaefer-Babajew D, Wang Z, Muecksch F et al (2022) Antibody feedback regulates immune memory after SARS-CoV-2 mRNA vaccination. Nature. https://doi.org/10.1038/s41586-022-05609-w . (Published online ahead of print, 2022 Dec 6) - DOI - PubMed - PMC
    1. Benschop RJ, Tuttle JL, Zhang L et al (2022) The anti-SARS-CoV-2 monoclonal antibody bamlanivimab minimally affects the endogenous immune response to COVID-19 vaccination. Sci Transl Med 14(655):eabn3041. https://doi.org/10.1126/scitranslmed.abn3041 - DOI - PubMed
    1. Perrier Q, Lupo J, Gerster T, Augier C, Falque L, Rostaing L, Pelletier L, Bedouch P, Blanc M, Saint-Raymond C, Boignard A, Bonadona A, Noble J, Epaulard O (2022) SARS-CoV-2 anti-spike antibodies after a fourth dose of COVID-19 vaccine in adult solid-organ transplant recipients. Vaccine 40(44):6404–6411. https://doi.org/10.1016/j.vaccine.2022.08.065 - DOI - PubMed - PMC
    1. Abedon AT, Teles MS, Alejo JL, Kim JD, Mitchell J, Chiang TPY, Avery RK, Tobian AAR, Levan ML, Warren DS, Massie AB, Garonzik-Wang JM, Segev DL, Werbel WA (2022) Improved antibody response after a fifth dose of a SARS-CoV-2 vaccine in solid organ transplant recipients: a case series. Transplantation 106(5):e262–e263. https://doi.org/10.1097/TP.0000000000004092 - DOI - PubMed - PMC

LinkOut - more resources